Indications span MF and PV in adults, plus acute/chronic GVHD in patients ≥12 years, positioning XR as a once-daily ...

Gardner highlights the vital role of caregivers in cancer care, emphasizing support gaps, shared experiences and ...

Hodgkin lymphoma arises from DNA mutations, yet individual causation often remains indeterminate despite known associations ...

SEER 1975–2023 analysis demonstrated a long-term mortality inflection from rising rates to sustained declines, with the ...

Late recognition of ARVC underscores diagnostic latency in inherited cardiomyopathies and the reality of progressive, ...

A confirmed MSH2-associated Lynch syndrome diagnosis provided a unifying biological explanation for multiple primary cancers ...

A three-time cancer survivor shares her journey with Lynch Syndrome and her transition from patient to advocate through a Lynch Syndrome vaccine trial.

Molecular/genomic profiling is expanding precision selection of systemic therapy and may enable immunotherapy-driven organ ...

ARVC while caring for his husband, finding hope through community and love.

FDA approval covers ER-positive/HER2-negative metastatic disease with ESR1 mutations after ≥1 endocrine line, with ...

Dr. Tony Anderson discusses balancing cancer treatment timing with fertility preservation and the ethical importance of ...